key: cord-1043572-pl7b1s2t
authors: Valitutti, Francesco; Verde, Alessandra; Pepe, Angela; Sorrentino, Eduardo; Veneruso, Deborah; Ranucci, Giusy; Orlando, Francesca; Mastrominico, Augusto; Grella, Mia Giovanna; Mandato, Claudia
title: Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era
date: 2021-04-08
journal: J Pediatr Surg Case Rep
DOI: 10.1016/j.epsc.2021.101838
sha: 0bdcabc637666a490c789c8e0eeefc8da49cfb13
doc_id: 1043572
cord_uid: pl7b1s2t

BACKGROUND/PURPOSE: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening condition occurring 2–6 weeks after Coronavirus disease 2019 (COVID-19) in previously healthy children and adolescents, characterized by clinical and laboratory evidence of multiorgan inflammation. We reported the case of a 6-year-old child presented with acute abdomen and then diagnosed with MIS-C. In addition, to better portray this new entity, we performed a systematic review of MIS-C gastrointestinal features and particularly on those mimicking surgical emergencies. METHODS: We described the clinical presentation, the diagnostic approach and the therapeutic outcomes of our MIS-C patient. Parallel to this, we conducted a systematic literature search using Google Scholar, PubMed, EMBASE, Scopus, focusing on gastrointestinal MIS-C. RESULTS: Our patient was initially assessed by the surgical team due to his query acute abdomen. Following the diagnosis of MIS-C with myocarditis, intravenous methylprednisolone (2 mg/Kg/day) and intravenous immunoglobulins (2 gr/Kg single infusion) were promptly started, leading to clinical improvement. According to our literature search, patients with MIS-C have a high rate of severe abdominal symptoms resembling surgical emergencies (appendicitis, obstruction, etc.) and a not negligible number of those patients have been surgically explored with variable findings. CONCLUSIONS: We encourage pediatric surgeons in the upcoming months of COVID-19 pandemic to evaluate myocardial function prior to surgical abdominal exploration. In children with query acute abdomen, MIS-C should be promptly ruled out in order to avoid unnecessary surgeries that could worsen the already frail outcome of this new syndrome. Nevertheless, it should be considered that MIS-C might well encompass complications (e.g. appendicitis, segmental intestinal ischemia) which need swift surgical treatment.

Author Contribution Form (*) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the manuscript contents. Allowing one's name to appear as an author without contributing significantly to the study or adding the name of an individual that has not contributed or has not agreed to the study in its current form is considered a breach of appropriate authorship and publication ethics. No individual other than the authors listed below should have contributed substantially to the preparation and revision of the manuscript. Ghost-writing is not acceptable.

Individuals who do not meet the criteria for authorship can be recognized and listed in the acknowledgments. This includes individuals that allow their clinical experience to be included in the study, those that provide only technical assistance, copyediting, proofreading or translation assistance, or a departmental leader that provided only general support including a department Chair.

For multi-institutional studies, groups of individuals and institutions that have materially contributed to the study but, whose contributions do not justify authorship may be listed in an appendix under a heading such as participating or clinical investigators. Their function should be described for example as a scientific advisor, critically reviewed the study proposal or participating institution.

Type the name of each author next to the appropriate following categories: -19) , in previously healthy children and adolescents. It is characterized by fever, laboratory evidence of inflammation (including increased ferritin and IL-6) and clinically severe illness requiring hospitalization with multisystem (>2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological); moreover, no alternative plausible diagnoses should be accountable and somewhat marker for current or recent SARS-CoV-2 infection should be present (RT-PCR, serology or antigen test) or COVID-19 exposure should fall within the 4 weeks prior to the onset of symptoms (Table 1) J o u r n a l P r e -p r o o f Initially, MIS-C was considered as Kawasaki-like because some clinical findings were reminiscent of Kawasaki's disease (KD) [3] . However, current data evidence some difference between these two conditions, such as the age of presentation: the majority of children with KD present before 5 years of age whereas MIS-C affects older children, with a mean age of 8 years [4] .

Gastrointestinal symptoms are the most common clinical manifestations of MIS-C (87% of children), followed by muco-cutaneous (73%), cardiovascular (71%), respiratory (47%) and neurologic symptoms in 22% [5] .

Abdominal pain, vomiting and diarrhea are particularly common and prominent, with the presentation in some children mimicking acute abdomen. Some children have been noted to have mesenteric adenitis, terminal ileitis and/or colitis on abdominal imaging [6] [7] [8] . An increasing number of children referred for suspected appendicitis or acute abdomen are subsequently diagnosed as MIS-C, often after undergoing surgery or after needing intensive care [9, 10] . Cardiac involvement includes ventricular dysfunction, coronary artery dilation or aneurysm, and arrhythmias [11] .

J o u r n a l P r e -p r o o f Coronary arteries may not be frequently affected in the acute phase and in the early follow-up period of MIS-C. The major finding during the acute phase of MIS-C is a myocarditis-like picture, which may remain subtle and subclinical [12] .

Severe pulmonary involvement (e.g. acute respiratory distress syndrome) is rather uncommon; however, when present, respiratory symptoms (tachypnea, dyspnea) are most often due to severe shock [13, 14] .

Neurocognitive symptoms are also frequent and may include headache, lethargy, confusion or irritability. A minority of patients presents with more severe neurologic manifestations, including encephalopathy, seizures, coma, meningoencephalitis, muscle weakness and brainstem/cerebellar signs [15] .

Herein we describe a new case of MIS-C presenting as acute abdomen and we outline a systematic review of the available literature on abdominal features of this condition.

The practical aim of this work is specifically to highlight MIS-C presenting as acute abdomen, a truly diagnostic and therapeutic dilemma for both pediatric surgeons and pediatric emergency physicians in the COVID-19 era. We report the case of a 6-year-old child who was admitted to a secondary-care hospital for fever (up to 40° C) lasting for five days and intermittent diarrhea. At admission he was pale, with palmar hyperemia; he presented regular cardio-respiratory activity, tense and painful abdomen, with signs of defense in the lower right quadrant; no lymphadenopathy was detected. Sars-Cov-2 testing through both antigenic and molecular nasopharyngeal swab resulted negative. Laboratory tests showed white blood cell count 7850/µL (neutrophils 83%, lymphocytes 10.6%), Hb 11.1 g/dl, platelets 114000/µL, Na+ 126 mEq/L, K+ 3.5 mEq/L, procalcitonin 14.6 ng/mL, C-reactive protein 16.10 mg/dl, fibrinogen 518 mg/dl, albumin 3.5 g/dl, liver function tests were within normal range. Anti-Sars-Cov-2 IgG antibodies were found positive. Ultrasonography evaluation of the abdomen highlighted free pelvic fluid and a non-visible appendix; a plain X-ray showed multiple hydro-aerial levels. This imaging, combined to clinical features and increased inflammatory indices, left the query appendicitis unsolved (Figure 1A and 1B). Although the clinical condition improved and cardiac function fully restored, he presented a persistent tense abdomen and weak peristalsis. Due to the lack of bowel movements and feeding intolerance, he received parenteral nutrition for 7 days. On day 8, we observed transient elevation of pancreatic enzymes (pAMY 192 IU/L lipase 474 IU/ L). Liver and renal function remained within the normal range. As D-dimer increased (2311 ng/ml), he was started on subcutaneous Enoxaparin. After day 12 of hospital stay, the patient was able to fully tolerate oral feeding and was discharged with aspirin (3 mg/kg/day) and oral Prednisone (2 mg/kg/day) then tapered in 15 days. Two weeks after discharge laboratory parameters, ECG, echocardiography and abdomen ultrasound were normal.

Serum IL-6 was tested on serum samples collected at entry and after treatment (297.4 pg/ml and 3.42 pg/ml, respectively; reference range 5.3-7.5 pg/ml).

The literature research was conducted from November 27 to January 27 on Google Scholar, Pub Med, EMBASE, Scopus using key-words as follows ( Table 2) J o u r n a l P r e -p r o o f RESULTS A total of 109 articles was retrieved from two authors blinded search, of which eleven were duplicate. Forty-eight were excluded as they were reviews, adult studies (>18 years), guidelines, commentaries, letters, morbidity/mortality report, case-series already reported in another paper included. A final set of 50 articles were suitable for the scope of our review.

Main clinical features of MIS-C reported patients are summarized (Table 3) .

When focusing on severe abdominal manifestations, we found nine patients affected by MIS-C who underwent exploratory laparotomies: two children with a healthy appendix as finding ("pseudo appendicular syndrome") [16, 17] , one with aseptic peritonitis [18] , four with appendicitis [19] and two with mesenteric lymphadenitis [20] . Appendicitis was initially suspected in roughly 5-30% [16, 18, [20] [21] [22] [23] [24] of the reviewed case series and in four case reports [9, 17, 25, 26] . Three patients underwent intestinal resection with re-anastomosis due to segmental inflammation with necrosis of terminal ileum [9, 27, 17] .

When considering imaging studies, ileitis or colitis were present approximately in 4-28% of cases [6, 7, 13, 23, [27] [28] [29] [30] [31] . Moreover, a diagnosis of mesenteric adenitis in MIS-C has been accounted by 8 case-series, with a prevalence of 9-20% of the abdominal imaging studies [6, 8, 13, 16, 23, 27, 31, 32] . In addition, the latter condition has been also described in six recent case-reports from different geographic areas [9, 25, 26, 30, 33, 34] : notably, in one of those patients mesenteric lymphadenitis was even confirmed on surgical specimens by pathologists [9] .

Vomiting and diarrhea were common presenting features, respectively in 23% and 21% of patients from the available literature.

Albeit predominant in our patient, intestinal occlusion was far less common and has been reported in 3 other patients so far [27, 30, 35] .

J o u r n a l P r e -p r o o f

The impact of COVID-19 on pediatric population can be considered relatively milder than adults [36] . Furthermore, the concern of contracting Covid-19, stay-at-home orders and population lockdowns have brought to a massive decrease of hospital accesses for children [37] .

Notwithstanding this, the fear of SARS-CoV-2 has often delayed pediatric consultations, thus leading to worse clinical outcomes [38] .

In this epidemiological framework, an increasing number of children has been described with a severe inflammatory disease characterized by fever, hyperinflammation and multiorgan involvement as short-medium term consequence of Sars-Cov2 infection, namely MIS-C. It is important to note that this newly recognized syndrome is most frequently post-infectious (related to an immune dysregulation induced by the virus, i.e. molecular mimicry) rather than related to acute infection [39] .

According to CDC criteria [2] , our patient could be fully labeled as MIS-C with acute abdomen and early myocarditis.

In this review of the literature, we summarized the features of MIS-C with a special focus on gastrointestinal involvement, thus addressing the need for an appropriate differential diagnosis both in the Emergency Room and during the early stages of hospital stay.

Quite surprisingly, in fact, patients with MIS-C have a high rate of gastrointestinal complaints.

Several authors reported acute abdomen presentation in a not negligible number of patients. Our systematic review of literature evidenced acute abdomen presentation up to 30% [16, 18, [20] [21] [22] [23] [24] . It is attractive to speculate that vascular damage could probably play a role as well with this regard.

Indeed, Khesrani et al. reported a case of ischemic lesions complicating MIS-C syndrome and formulated the hypothesis of an underlying severe intestinal vasculitis [17] .

A case report by Cazzaniga et al. described a child with KD complicated by the onset of paralytic ileus: this patient also resulted positive for SARS-COV-2 and his X-ray showed ileocolic meteorism with diffuse air-fluid levels, compatible indeed with paralytic ileus associated to intestinal vasculopathy [40] . Nonetheless, it should be noted that this case was not an outcome of our search nor present in Table 3 because classified as KD rather than MIS-C.

In our opinion, for these unclear cases it is definitely valuable a period of watchful monitoring in a hospital setting. Subsequently, if the clinical picture does not improve, a different abdominal imaging might be required. Should patient's clinical status worsen further, an extensive abdominal imaging (MR angiogram preferably or CT angiogram) must be considered, as well as to promptly establish the best treatment and to avoid complications.

Given the high rate of severe abdominal symptoms resembling surgical emergencies (query appendicitis or obstruction) in MIS-C, we encourage pediatric surgeons in the upcoming months to evaluate myocardial function prior to surgical abdominal exploration. Few laboratory and imaging tools should become full part of the initial diagnostic panoply. A preliminary assessment of troponin, BNP, D-Dimer, ferritin and echocardiography are definitely of value to establish a precise differential diagnosis in children with acute abdomen, as it was in our case. Considering the high J o u r n a l P r e -p r o o f overlap between gastrointestinal and cardiac involvement in MIS-C, evolution towards cardiogenic shock should not be neglected, especially when avoidable surgery might worsen its already frail outcomes. Nevertheless, it must be acknowledged that several cases of MIS-C do evolve in insidious surgical complications such as appendicitis and vasculopathy-related segmental intestinal infarction. Rather than being ancillary, the role of pediatric surgeons in MIS-C is thus key and so it will be in the months ahead of current pandemic.

In conclusion, the awareness on the high rate of gastrointestinal complaints in MIS-C is definitely an added value for both pediatricians and pediatric surgeons. A multidisciplinary approach is more than desirable for these children, with both team's side-by-side against possible confounders and hazardous complications, always aiming to the best therapeutic outcome.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f Table 3 : Review of the literature. Table 3 contains references from 41 onwards (not cited elsewhere in the manuscript). For brevity and clarity Table 3 has been uploaded as separate file 1) An individual aged < 21 years with:

2) Clinical criteria: -Fever > 38C° for ≥ 24 hours, or report of subjective fever lasting ≥ 24 hours AND -Severe illness necessitating hospitalization AND -Two or more organ involvement (i.e., cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic, neurological)

3) Evidence of inflammation:

-One or more of the following: an elevated CRP, ESR, fibrinogen, procalcitonin, D-dimer, ferritin, LDH, or IL-6; elevated neutrophils, reduced lymphocytes; low albumin 4) Laboratory or epidemiologic evidence of SARS-CoV-2 infection: -Positive for current or recent SARS-COV2 infection by RT-PCR, serology or antigen test; -Exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. 

American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2

Emergency preparedness and response: health alert network

MIS-C: early lessons from immune profiling

Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States

Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review

Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe

Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series

Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

A Case of Multisystem Inflammatory Syndrome in Children Mimicking Acute Appendicitis in a COVID-19 Pandemic Area

Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach

Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States

Multisystem inflammatory syndrome in children (MIS-C) during SARS

CoV-2 pandemic in Brazil: a multicenter, prospective cohort study

Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth

Neurological issues in children with COVID-19

Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran

Intestinal ischemia secondary to Covid-19

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic

Acute appendicitis in four children with SARS-CoV-2 infection

Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)

Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome -Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children

Abdominal Imaging Findings in Critically Ill Children With Multisystem Inflammatory Syndrome Associated With COVID-19

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Multisystem Inflammatory Syndrome in Children Mimicking Surgical Pathologies: What Surgeons Need to Know about MIS-C

The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children

Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children

Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City

Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran

ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child

Multisystem Inflammatory Syndrome in Children in New York State

Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases

Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia

Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report

COVID-19 Infection in a Child Presenting With Functional Intestinal Obstruction

COVID-19 in Children: Initial Characterization of the Pediatric Disease

Effect of Population Lockdown on Pediatric Emergency Room Demands in the Era of COVID-19

Delayed access or provision of care in Italy resulting from fear of COVID-19

System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV

Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management

SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association

Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain

Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic

Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with severe acute respiratory syndrome coronavirus 2 Infection

Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain

COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection

COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study

Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital

Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2

MIS-C and Cardiac Conduction Abnormalities

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19

COVID-19 in pediatric patients: a case series from the Bronx, NY

Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19

Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in an 8-week old infant

COVID-19-Associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis

Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19

Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children

A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease

Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience

All the authors warmly thank Prof. Pietro Vajro for his expert supervision and fruitful discussion on both patient case and manuscript preparation.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Consent to publish the case report was not obtained. This report does not contain any personal information that could lead to the identification of the patient J o u r n a l P r e -p r o o f